Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Desloratadine
Cat. No.:
OB0225LY-0160
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Desloratadine is a non-sedating antihistamine with selective H1 receptor antagonism.
Synonym:
Sch34117; NSC 675447; 100643-71-8; Descarboethoxyloratadine; 8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine; 5H-Benzo[5,6]cyclohepta[1,2-b]pyridine, 8-chloro-6,11-dihydro-11-(4-piperidinylidene)-; 13Chloro-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene; 8-Chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine (Descarboethoxyloratadine; Desloratadine)
CAS No.:
100643-71-8
Compound CID:
124087
Formula:
C19H19ClN2
Formula Weight:
310.82
Specification
Relative Density:
1.221 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Desloratadine can be used to study the pathological mechanisms of allergic diseases or play an important role in the screening of anti-allergic drugs.
Library Information
Targets:
Histamine receptor
Receptors:
H1 receptor
Pathways:
Immunology/Inflammation; GPCR/G protein; Metabolism; Neuronal signaling
Plate Number:
AOCL-3
Plate Location:
a3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
40 mg/mL; 128.69 mM
Ethanol Max Solubility:
31.1 mg/mL; 100 mM
